(PRESS RELEASE) PARIS, 20-Jul-2021 — /EuropaWire/ — French mass-market retail company Casino Group (EPA: CO) has announced that it has extended the maturity and improved the financial conditions of its main syndicated credit facility, originally set to mature in October … Read the full press release
(PRESS RELEASE) PARIS, 20-Jul-2021 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced fexinidazole approval by the US Food and Drug Administration (FDA) as the first all-oral treatment for both stages of the … Read the full press release
Posted in France, Healthcare, News, Pharma & Biotech
Tagged Central African Republic, Democratic Republic of Congo, DNDi, Dr Bernard Pécoul, Drugs for Neglected Diseases initiative, FDA, fexinidazole, HAT, Human African trypanosomiasis, Luc Kuykens, National Sleeping Sickness Programs, neuropsychiatric symptoms, parasitic disease, Sanofi, sleeping sickness, Trypanosoma brucei gambiense, tse-tse fly, US Food and Drug Administration, WHO, World Health Organization
Why identical mutations cause different types of cancer Cancer development is influenced by tissue type (PRESS RELEASE) MUNICH, 20-Jul-2021 — /EuropaWire/ — Technical University of Munich (TUM), one of Europe’s leading universities, has announced that its Professor for Translational Cancer … Read the full press release
Posted in Education, Germany, Healthcare, News, Science, Technology
Tagged biliary tract cancer, Cancer, cancer drivers, cancerous diseases, Chiara Falcomatà, Dieter Saur, DKTK, extrahepatic bile duct cancer, Functional Genomics, Genes, German Cancer Consortium, Günter Schneider, human cancers, Klinikum rechts der Isar, KRAS, Molecular Oncology, oncogenes, organs, pancreatic cancer, PIK3CA, Roland Rad, Technical University of Munich, treatment of pancreatic cancer, treatments of cancerous diseases, TUM, University Medical Center Göttingen
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
